about
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbot...
Read More
0.16
-0.01
(-5.88%)
862.2K
XNAS Volume
XNAS 13 Mar, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
BioAtla Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..